About Argá Medtech
Argá Medtech is a company based in Epalinges (Switzerland) founded in 2020 by David Neale and Randy Werneth. Argá Medtech has raised $58.52 million across 1 funding round from investors including Advent Life Sciences, Earlybird and Gilde Healthcare. Argá Medtech offers products and services including Pulsed Field Ablation System and Proprietary Catheter. Argá Medtech operates in a competitive market with competitors including Kardium, Adagio Medical, Farapulse, Affera and Field Medical, among others.
- Headquarter Epalinges, Switzerland
- Founders David Neale, Randy Werneth
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Argá Medtech Sa
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$58.52 M (USD)
in 1 rounds
-
Latest Funding Round
$58.52 M (USD), Series B
Feb 27, 2024
-
Investors
Advent Life Sciences
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Argá Medtech
Argá Medtech offers a comprehensive portfolio of products and services, including Pulsed Field Ablation System and Proprietary Catheter.
Non-thermal system for safe cardiac ablation to treat arrhythmias.
Catheter designed for versatile use in ablation procedures.
People of Argá Medtech
Unlock access to complete
Unlock access to complete
Funding Insights of Argá Medtech
Argá Medtech has successfully raised a total of $58.52M through 1 strategic funding round. The most recent funding activity was a Series B round of $58.52 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Argá Medtech
Argá Medtech has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Advent Life Sciences, Earlybird and Gilde Healthcare.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early and mid-stage life science focused VC firm investing in the US and Europe
|
Locked | Locked | Locked | |
|
Earlybird is recognized as a venture capital investor focused on early-stage tech companies.
|
Locked | Locked | Locked | |
|
Private equity and venture captial firm focused on healthcare sectors
|
Locked | Locked | Locked |
Investor details for Argá Medtech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Argá Medtech
Investment portfolio details for Argá Medtech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Argá Medtech
Detailed financials for Argá Medtech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Argá Medtech Comparisons
Peer comparison for Argá Medtech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Argá Medtech
Argá Medtech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kardium, Adagio Medical, Farapulse, Affera and Field Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Atrial fibrillation ablation devices are developed by Kardium.
|
|
| Locked | Locked | Locked |
Cardiovascular therapies are developed by Adagio Medical in stealth mode.
|
|
| Locked | Locked | Locked |
Devices for cardiac ablation via pulsed field technology are developed.
|
|
| Locked | Locked | Locked |
Devices for treating heart rhythm disorders are developed.
|
|
| Locked | Locked | Locked |
Pulsed electric field ablation devices for heart arrhythmias are developed.
|
Detailed competitors of Argá Medtech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Argá Medtech
Complete news archive for Argá Medtech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Argá Medtech
Argá Medtech was founded in 2020 and raised its 1st funding round 4 years after it was founded.
Argá Medtech is headquartered in Epalinges, Switzerland. It is registered at Epalinges, Vaud, Switzerland.
David Neale is the current CEO of Argá Medtech. They have also founded this company.
Argá Medtech is a funded company, having raised a total of $58.52M across 1 funding round to date.
Argá Medtech was founded in 2020 and is based in Epalinges, Switzerland. Focus is placed on the development of medical devices within the cardiac health sector. Pulsed field ablation and irreversible electroporation technologies are advanced for arrhythmia treatment. Operations center on innovation in electrophysiology tools, with regulatory and clinical oversight managed internally to support device progression toward clinical applications.
Argá Medtech's top competitors include Kardium, Adagio Medical and Field Medical.
Argá Medtech offers Pulsed Field Ablation System and Proprietary Catheter.
Argá Medtech has 3 investors. Key investors include Advent Life Sciences, Earlybird, and Gilde Healthcare.